You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diet, nutrition and obesity

Setmelanotide for treating obesity caused by LEPR or POMC deficiency

  • Highly specialised technologies guidance
  • Reference number: HST21
  • Published:  06 July 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Case studies
  2. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Case studies

  • Injectable anti-obesity medications in specialist weight management services: supporting people with complex needs

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top